The battle against COVID-19 has ignited a surge in the America’s COVID-19 Testing Market. According to a recent analysis, the market, valued at USD 5.1 billion in 2022, is projected to reach a significant USD 9.8 billion by 2033. This impressive growth translates to a Compound Annual Growth Rate (CAGR) of 6.7% during this period.
The growing number of COVID-19-infected patients, treatment procedures, and R&D activities are increasing the demand for America’s COVID-19 testing. In addition, the increasing demand for sampling kits, health concerns, and detection of COVID-19 symptoms such as cough, mild-fever cold, and body pain have raised the adoption of America’s COVID-19 testing during the forecast period.
The rising demand for Nasopharyngeal swab samples among patients due to their high availability is anticipated to drive market expansion. In addition, the easy availability of COVID-19 self-testing kits at home is further driving the adoption of online purchasing on e-commerce platforms.
Healthcare manufacturers are developing innovative diagnostic kits to control the infection of COVID-19. On the other hand, rising complications in the COVID-19 testing equipment slow down the market growth. In addition, launching vaccine doses by medical institutes also restrains the market share.
Request for a Sample copy of this Report:
Scope of Online Sales Channel in the Market?
In the last few years, the adoption of online sales channels among the end-users is increased the market expansion. As a result, based on the distribution channel, the online sales channel leads the global market by securing a higher CAGR during the forecast period.
The online sales channel provides certain discounts, coupons, and product offers that will likely attract consumers’ attention and increase market opportunities during the forecast period. In addition, the high acceptance and convenience of end-users primarily increase the adoption of online sales channels due to home delivery and reduced costs.
Top Countries Performance in the Americas COVID-19 Testing Market
The U.S. market secures a CAGR of 6.5% with a valuation of 3.5 Bn during the forecast period. Technological advancement, innovative products, and license agreements are driving the U.S. Americas COVID-19 testing market size. As a result, the prominent players are making strategies and implementing plans that are driving market expansion.
On the other hand, the U.K. is smoothly capturing a CAGR of 5.8% during the forecast period. Government regulations, high technology, new policies, and essential players are expanding the U.K. Americas COVID-19 testing market opportunities.
In addition, the growing healthcare sector, laboratories, and clinics are uplifting market growth. As a result, the U.S. is estimated to hold a valuation of US$ 412.4 Bn during the forecast period.
Key Takeaways:
- The Americas COVID-19 Testing marketis expected to have a valuation of US$ 9.8 Bn by 2033.
- With a CAGR of 6.7%, the global market is increasing during the forecast period.
- The market in the United States is anticipated to grow at a CAGR of 6.5% through 2033.
- With a CAGR of 5.8%, the UK market significantly uplifts during the forecast period.
- The China market is expected to grow at a CAGR of 6.2% over the forecast period.
Who is Winning?
The market is consolidated by the number of present players globally during the forecast period. The players are innovating and launching new testing equipment to detect COVID-19 infection. These players are capturing end-users attention by providing advanced testing equipment.
The prominent vendors are growing the market by adopting several marketing tactics such as mergers, acquisitions, partnerships, collaborations, and agreements.
Some of the Leading Companies Operating in the Market are:
- Sky Medical Supplies & Equipment LLC.
- Sugentech, Inc.
- Novacyt Group
- Aurora Instruments Ltd.
- PRIMA Lab SA
- SD Biosensor, INC.
- Gold Standard Diagnostics
- Eurofins Technologies
- Biomerieux SA
- Danaher
Use promo code ->> FMITODAY to get a flat 20% discount
Recent Developments in the Americas COVID-19 Testing Market:
- In Dec 2021, Trusted Laboratory DIPM announced that the FDA approved COVID-19 emergency RT-PCR test that would detect omicron variants.
- In Oct 2021, PerkinElmer Inc announced the authorization of Respiratory SARS-CoV-2 RT-PCR issued by the U.S. FDA.
Americas COVID-19 Testing Market by Category
By Test Type:
- SARS-CoV2 IgM/IgG Antibody Rapid Test Kits
- SARS-CoV-2 Antigen Rapid Test Kits
- Multiplex Real-time RT-PCR Assay Kits
By Sample Type:
- Blood
- Nasopharyngeal Swabs
By Distribution Channel:
- Hospital Pharmacies
- Diagnostic Laboratories
- Retail Pharmacies
- Drug Store
- Online Sales Channel
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube